Phase 1
Receipt and Initial Triage
1Log the complaint upon receipt
Every complaint logged immediately with all available details, including product name, lot number, description of the issue, and complainant contact information.
21 CFR 211.198
↓
2Verify complaint completeness
Follow up with the complainant if key identifying details are missing, since incomplete information can prevent an effective investigation later.
EU GMP Chapter 8
↓
3Perform initial severity triage
Complaint assessed against pre-defined criteria to assign an initial severity classification, driving the urgency and depth of the response that follows.
21 CFR 211.198
↓
Does the complaint indicate a potential safety issue or regulatory reporting trigger?
YES → Escalate immediately
NO → Proceed to standard investigation
Phase 2
Investigation and Classification
4Retrieve retained sample and batch records
Retained sample from the implicated lot retrieved where available, alongside the complete batch manufacturing and QC record for that lot.
21 CFR 211.170 · 211.198
↓
5Classify the complaint per defined criteria
Final classification assigned as critical, major, or minor based on the complete information gathered, which may differ from the initial triage assessment.
21 CFR 211.198
↓
6Assess sample availability for examination
Determine whether the complainant's returned sample, if any, is available for physical or laboratory examination, which substantially strengthens the investigation's evidentiary basis.
EU GMP Chapter 8
↓
7Perform lab testing or physical examination
Returned sample tested or physically examined where available, with results documented and compared against the retained sample from the same lot.
21 CFR 211.198
Phase 3
Root Cause and Impact Assessment
8Correlate with manufacturing and QC records
Complaint details correlated against the implicated batch's manufacturing history, QC results, and any deviations recorded during production.
21 CFR 211.198
↓
9Assess batch and related-batch impact
Determine whether other batches sharing the same materials, equipment, or process conditions may also be affected, including whether the finding warrants recall consideration.
EU GMP Chapter 8
↓
10Determine root cause with objective evidence
Root cause conclusion supported by the batch record review, any sample testing performed, and correlation with related quality data.
ICH Q10
Phase 4
Response, CAPA, and Closure
11Communicate outcome to the complainant
Response communicated to the complainant summarizing the investigation outcome, in a manner and timeframe consistent with the site's complaint handling procedure.
EU GMP Chapter 8
↓
12Implement CAPA and update trends
Corrective and preventive actions implemented as warranted, with the complaint added to the site's ongoing complaint trend dataset by product and issue type.
ICH Q10
↓
13QA review and final closure
Quality unit reviews the complete complaint file and formally closes it, with the record retained per 21 CFR 211.198 documentation requirements.
21 CFR 211.198
Severity Classification Considerations
Safety and Efficacy Signals
Any complaint suggesting a potential adverse event, wrong active ingredient, or other safety-relevant issue is treated as critical and escalated immediately, regardless of how it was initially reported.
21 CFR 211.198
Quality Defects Without Immediate Safety Impact
Genuine product defects, such as an appearance abnormality or a suspected specification failure, classified as major and formally investigated even absent an apparent safety concern.
EU GMP Chapter 8
Cosmetic and Non-Quality Issues
Packaging or labeling issues with no bearing on product quality classified as minor, though still logged and trended to catch any recurring pattern.
21 CFR 211.198
Regulatory Escalation Response Steps
Step 1 - Notify quality and medical/regulatory affairs immediately
Escalate without delay for any complaint suggesting a potential safety signal or regulatory reporting trigger.
Step 2 - Assess regulatory reporting obligations
Determine whether the complaint meets the threshold for a Field Alert Report, adverse event report, or other formal regulatory notification.
Step 3 - Evaluate recall or market action need
Assess batch and related-batch scope to determine whether a field correction, recall, or other market action is warranted.
Step 4 - Meet statutory notification deadlines
Ensure any required regulatory notification is submitted within the applicable statutory timeframe, tracked independently from the broader investigation timeline.
Step 5 - Document the escalation decision fully
Record the rationale for the escalation decision and any regulatory notification made, or the rationale for determining notification was not required.
Documentation Requirements
Complete complaint identification
Product name, lot number, complainant information, and a clear description of the issue captured for every complaint received.
Investigation findings and conclusion
Findings from batch record review, sample testing, and root cause analysis documented within the complaint file itself.
Response and closure record
Communication sent to the complainant and the final closure rationale retained as part of the complete complaint file.
Retention per regulatory requirement
Complaint files retained for the period specified by applicable regulation, commonly matching or exceeding the product's shelf life plus one year.